Science Friday

COVID Near You Citizen Science, Fact-Check Your Feed. March 27, 2020, Part 1

03.27.2020 - By Science Friday and WNYC StudiosPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

These days, our newsfeeds are overloaded with stories of the coronavirus. This week, Science Friday continues to dig into the facts behind the speculation—the peer-reviewed studies and reports published by scientists investigating the virus.

But what we know—and don’t know—about the new virus is changing daily, making it hard to keep up. Everyone, for example, wants to know more about possible therapies for treating COVID-19 patients. After President Trump publicly speculated about the tried and true antimalarial drug, hydroxychloroquine, his endorsement sent governors, doctors, and the worried public scrambling to get their hands on the drug. But is there any science to back-up this claim? And what about remdesivir, the antiviral drug that has been used to treat a handful of patients, and is now the subject of several new drug trials?

Angela Rasmussen, associate research scientist and virologist at the Columbia Mailman School of Public Health joins Science Friday once again to break down the science behind the stories.

As suspected and confirmed cases of COVID-19 skyrocket in the United States, testing availability remains limited, leaving people wondering if their cough is something to worry about. But testing isn’t just a balm for anxiety—public health officials need data about how far the new virus has spread to make decisions about how to best protect people, and where to send critical resources, like masks and gowns. Accurate information is the frontline of defense, but scientists still have pressing questions about the novel disease. For instance, how many people who are infected actually have symptoms? If you do have symptoms, how likely are you to get severely sick?

Until we are able to test both healthy and symptomatic people at scale, citizen science can help fill the gaps in tracking who has COVID-19. And the public health team that launched Flu Near You to track seasonal flu symptoms is now doing just that: soliciting your symptoms in the Covid Near You project.

Covid Near You co-founder John Brownstein of Boston Children’s Hospital explains what questions the project may help answer, and what trends Covid Near You will track—including why this data is so valuable to public health efforts. Sign up at www.covidnearyou.org to report how you’re feeling—whether you’re healthy or have symptoms.

More episodes from Science Friday